DKSH ups South Korean presence

DKSH, the Asia-focused drug marketer, has expanded its heft in South Korea, opening a new distribution in Seoul aimed to help its medical device clients place products around the country.

The roughly 14,000-square-foot facility meets Korean Good Supplying Practices, the company said, with space for more than 20,000 units of devices, pharma products and medical supplies. 

"Our new distribution center complements our existing healthcare distribution centers in Korea and will support the enhancement of our capabilities to better support the growth of our clients and customers in the country," Joo-Hwan Han, DKSH's healthcare manager in Korea, said in a statement. "Focusing on medical devices, the distribution center will help DKSH to strengthen its position as partner of choice for medical devices companies who want to expand their business in Korea."

The Swiss-headquartered DKSH makes its name helping global companies expand their market presence in Asia, and its healthcare arm has led the way to growth over the past year. Last month, DKSH signed up with GlaxoSmithKline ($GSK) to market antibiotic products in Hong Kong, and, earlier this year, the company signed deals with Pfizer ($PFE) and Bayer covering Cambodia.

Last year, DKSH's healthcare business grew roughly 27.3%, grossing about $3.9 billion thanks in part to a deal with Sanofi ($SNY) to expand in Laos and an earlier agreement with GSK covering Cambodia.

- read the announcement

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.